Tag Archive for LifeVantage

LifeVantage Launches TrueScience® Activated Skin Care Collection

LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health at the cellular level, is proud to announce the launch of its TrueScience® Activated Skin Care Collection, marking a significant advancement in skincare technology and formulation.
Building on the successful October 2023 launch of TrueRenew Daily Firming Complex, a better-than-retinol alternative, LifeVantage’s entire skincare offering has been enhanced to provide skin health activation in every step. The Collection delivers a simple regimen of multi-tasking products that meet the sophisticated needs of today’s busy consumers.
The products were first revealed March 2 in Canada and Europe where they were immediately available to Consultants and Customers. The global launch continues throughout the month and into April, as they launch at various market events across the globe.
The reimagined TrueScience lineup features TrueRenew plus three, refreshed, reimagined, clean product formulas: TrueClean Refining Cleanser, TrueLift Illuminating Eye Cream, and TrueHydrate Brightening Moisturizer. Each is designed with cutting-edge science, including a patented Nrf2 ingredient blend plus additional premium, planet-friendly ingredients proven to support skin health and deliver visible anti-aging results, including brighter skin in as little as seven days.
Steve Fife, President and CEO of LifeVantage, expressed his excitement about the new collection:

“TrueRenew

Read more...

LifeVantage Q3 Revenue $51.4 Million

LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes, today reported financial results for its first fiscal quarter ended September 30, 2023.

First Quarter Fiscal 2024 Summary*:

Revenue of $51.4 million, a decrease of 0.8% from the prior year period. Excluding the negative impact of foreign currency fluctuations, first quarter revenue was down approximately 0.2%;
Revenue in the Americas increased 5.9%, including a 6.5% increase in the United States. Revenue in Asia/Pacific & Europe decreased 16.6% and was down approximately 14.6% excluding the negative impact of foreign currency fluctuations;
Total active accounts declined 10.5% from the prior year period to 137,000, reflecting a 7.5% decline in the Americas and a 17.0% decline in Asia/Pacific & Europe;
Net income per diluted share were $0.05, versus $0.05 per diluted share a year ago;
Adjusted earnings per diluted share was $0.13, compared to $0.06 a year ago; and
Adjusted EBITDA increased 41.4% to $4.0 million.

* All comparisons are on a year over year basis and compare the first quarter of fiscal 2024 to the first quarter of fiscal 2023, unless otherwise noted.

“We are very pleased with our first quarter results, which further demonstrate the effectiveness of LV360 in driving growth and profitability,”

said Steve Fife, President and Chief Executive Officer of Life Vantage.

“Revenue in the U.S. was up 6.5%, reflecting continued strength in key products, including a

Read more...

LifeVantage Ranked As Triple AAA+ Opportunity For 2023 And 2024

LifeVantage is a public network marketing company that has received an exceptional Business for Home rating of AAA+.
Their remarkable success reflects their commitment to providing an astounding opportunity. With a revenue of $213 million in 2022, it is evident that this business holds interesting potential. In fact, as much as 48% of this revenue could have been distributed as commission, offering individuals a motivating chance to achieve their goals.
LifeVantage is ranked as a AAA+: An awesome opportunity. This makes LifeVantage a top recommendation from Business For Home for 2023 and 2024.
The ranking is based on a number of facts and figures such as:

Momentum ranks
Simular web ranks
Company page views
Company reviews by distributors
YouTube view ranks
YouTube subscribers ranks
Revenue growth in %
Revenue growth in $ Millions
Nr of top earners 
Company head office visits
Conventions we visit all of the world
Company Recommended distributors
Insider information

We have classified the companies in our database into 4 ranks or grades, about:

  5% has a AAA+ ranking, the highest recommendation.
30% has a AA+ ranking.
35% has a A+ ranking.
30% has a B ranking.

Above data is available in the Business For Home app, both for Android as iOS. We recommend to download the (Free) app below.
LifeVantage in the news
LifeVantage, a network marketing company, has

Read more...

Nearly 300 Leaders Announce Support for Existing LifeVantage Board

LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products designed to activate optimal health processes, issued the following statement in response to a press release issued by Bradley L. Radoff and Sudbury Capital Fund, LP (collectively with the other participants in their solicitation, the “Radoff-Sudbury Group”):

“LifeVantage did not compensate any consultant for providing a statement to the media regarding the consultants’ perspectives on LifeVantage’s strategy, Board of Directors and leadership team.
The nearly 300 consultants who signed the statement in support of the Company –who are responsible for over 80% of the Company’s net revenue – did so voluntarily, independently and without any compensation. LifeVantage took no part in drafting the consultants’ statement.
The Radoff-Sudbury Group’s allegations to the contrary are simply false.”

LifeVantage earlier press release:
A coalition of nearly 300 Senior Marketing Consultants to LifeVantage Corporation who represent more than 80 percent of the company’s revenue, announced their support for the existing company Board and management.
Many of the company’s Field Advisory Board Members signed an open letter expressing confidence in the existing leadership and direction of the company.
Tyler Daniels, a LifeVantage Field Advisory Board Member who helped organize the coalition of signers, said,

“In unity, we

Read more...

LifeVantage A Review For Prospects

LifeVantage is a reputable global public (Nasdaq) company that offers health and wellness products and is a pioneer in nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health.
The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath & body, and targeted relief products.
Many wonder if joining LifeVantage as a distributor can generate extra income. While we can’t make any promises, it’s worth noting that in 2022, LifeVantage generated an impressive revenue of $213 million, indicating its success.
Additionally, with 48% of that revenue potentially going towards commission, opportunities may exist for those who join. Remember, outcomes may vary, but LifeVantage offers an inspiring path towards financial potential.
LifeVantage in Facts and Figures
LifeVantage, headed by CEO Steve Fife, displayed a modest yet pronounced performance in its 2022 fiscal results. The company, which is situated in the United States, recorded a revenue of $213 million marking a 3% increase from the 2021 figures. Interestingly, the compensation plan managed to pay out a decent 48%, which summed up to about $102 million in commission.
The company’s reputation is further animated

Read more...

LifeVantage Q4 Revenue Up 6.4 % To $54.2 Million

LifeVantage Corporation (Nasdaq: LFVN) a leading health and wellness company with products designed to activate optimal health processes, today reported financial results for its fourth quarter and full fiscal year ended June 30, 2023.
Fourth Quarter Fiscal 2023 Summary*:

Revenue of $54.2 million, an increase of 6.4% from the prior year period. Excluding the negative impact of foreign currency fluctuations, fourth quarter revenue was up approximately 7.8%;
Revenue in the Americas increased 17.9% including an 18.6% increase in the United States.
Revenue in Asia/Pacific & Europe decreased 16.0% and was down approximately 3.9% excluding the negative impact of foreign currency fluctuations;
Total active accounts declined 8.3% from the prior period to 143,000, reflecting a 3.8% decline in the Americas and a 18.0% decline in Asia/Pacific & Europe;
Net income per diluted share were $0.15, versus loss of $0.11 a year ago;
Adjusted earnings per diluted share were $0.17, compared to $0.01 a year ago; and
Adjusted EBITDA of $4.8 million, compared to $1.7 million a year ago.

* All comparisons are on a year over year basis and compare the fourth quarter of fiscal 2023 to the fourth quarter of fiscal 2022, unless otherwise noted.
Fiscal Year 2023 Summary**:

Revenue increased 3.4% to $213.4 million. Excluding the negative impact of

Read more...

LifeVantage Appoints New President and Director of Japan

LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes, recently announced the appointment of Michael Allen as President and Director of LifeVantage Japan.
Mr. Allen has over 30 years of experience in the Asia-Pacific region, serving in executive, sales, marketing, finance, and operational roles for multiple direct selling companies including Forever Living, Avon, and Amway.
Most recently, Mr. Allen was CEO at CMA-Interactive, a company he co-founded to specialize in business transformations.
“Michael joins us at a pivotal time as our LV360 strategic transformation initiatives, including our new, modern Consultant compensation plan, Evolve, and Customer loyalty program roll out to Japan’s dynamic leaders and culture,”
said Kristen Cunningham, Chief Sales Officer of LifeVantage.
“His broad, deep experience in the region, including his time transforming other businesses, solidifies him as the right leader for this growing LifeVantage market. We are so pleased to have him on the team.” 
Mr. Allen’s enthusiasm for transformation stems from his core values. He credits his passion for the industry to its ability to provide possibilities to anyone looking to add value to their life.
“What really excites me is helping others to fulfill their passions,”
said Mr. Allen.
“I believe true, sustained success is achieved by

Read more...

LifeVantage Q3 Fiscal 2023 – Revenue Up 7.5% to $53.7 million

LifeVantage Corporation (Nasdaq: LFVN) recently reported financial results for its third fiscal quarter ended March 31, 2023.
Third Quarter Fiscal 2023 Summary*:

Revenue of $53.7 million, an increase of 7.5% from the prior year period. Excluding the negative impact of foreign currency fluctuations, third quarter revenue was up approximately 10.4%;
Revenue in the Americas increased 18.2% including a 19.5% increase in the United States. Revenue in Asia/Pacific & Europe decreased 14.2% and was down approximately 5.1% excluding the negative impact of foreign currency fluctuations;
Total active accounts declined 5.1% from the prior year period to 149,000, reflecting flat accounts in the Americas and a 16.3% decline in Asia/Pacific & Europe;
Net income per diluted share were $0.08, versus $0.09 per diluted share a year ago;
Adjusted earnings per diluted share were $0.08, versus $0.12 a year ago;
Adjusted EBITDA of $3.3 million, compared to $3.4 million a year ago; and
Strong balance sheet with $19.5 million of cash and no debt.

* All comparisons are on a year over year basis and compare the third quarter of fiscal 2023 to the third quarter of fiscal 2022, unless otherwise noted.

“Third quarter results demonstrate significant early progress of our LV360 strategic transformation initiatives, including our new Evolve compensation plan,”

said Steve Fife, President and Chief

Read more...

LifeVantage Sales Up 2.8% To $53.7 Million

LifeVantage Corporation (Nasdaq: LFVN) today reported financial results for its second fiscal quarter ended December 31, 2022.
Second Quarter Fiscal 2023 Summary*:

Revenue of $53.7 million, an increase of 2.8% from the prior year period. Excluding the negative impact of foreign currency fluctuations, second quarter revenue was up approximately 7.4%;
Revenue in the Americas increased 14.4% including a 15.4% increase in the United States. Revenue in Asia/Pacific & Europe decreased 20.2% and was down approximately 7.0% excluding the negative impact of foreign currency fluctuations;
Total active accounts declined 8.6% from the prior year period to 149,000, reflecting a decline of 7.1% in the Americas and a 12.0% decline in Asia/Pacific & Europe;
Net loss per diluted share were $0.08, versus net income of $0.01 per diluted share a year ago;
Adjusted loss per diluted share were $0.07, versus adjusted earnings per diluted share of $0.05 a year ago;
Adjusted EBITDA of $0.8 million, compared to $1.9 million a year ago; and
Strong balance sheet with $17.4 million of cash and no debt.

* All comparisons are on a year over year basis and compare the second quarter of fiscal 2023 to the second quarter of fiscal 2022, unless otherwise noted.

“We reached a positive inflection point in the second quarter, delivering year-over-year revenue growth of

Read more...

LifeVantage Revenue Fiscal Year 2022 Down 6% To $206.4 Million

LifeVantage Corporation today reported financial results for its fourth quarter and full fiscal year ended June 30, 2022.
Fourth Quarter Fiscal 2022 Summary*:
Revenue of $50.9 million, a decrease of 7.0% from the prior year period. Excluding the negative impact of foreign currency fluctuations, fourth quarter revenue was down approximately 3%;

Revenue in Asia/Pacific & Europe increased 0.7%
Revenue in the Americas decreased 10.5%.
Excluding the negative impact of foreign currency fluctuations, fourth quarter revenue in Asia/Pacific & Europe increased approximately 12.8%;
Total active accounts declined 8.2% from the prior period to 156,000, reflecting a 10.9% decline in the Americas and a 2.0% decline in Asia/Pacific & Europe;
Loss per diluted share were $0.11, versus earnings per diluted share of $0.35 a year ago;
Adjusted earnings per diluted share were $0.01, compared to $0.31 a year ago;
Adjusted EBITDA of $1.7 million, compared to $6.6 million a year ago; and
Repurchased 103,391 shares.

*All comparisons are on a year over year basis and compare the fourth quarter of fiscal 2022 to the fourth quarter of fiscal 2021, unless otherwise noted.
Fiscal Year 2022 Summary**:

Revenue decreased 6.3% to $206.4 million.
Excluding the negative impact of foreign currency fluctuations, fiscal year 2022 revenue was down approximately 4.2%;
Revenue in Asia/Pacific & Europe increased 3.8% and revenue

Read more...